マテリアル事業

ホソカワミクロン株式会社 マテリアル事業本部

doi:10.24611/micromeritics.2022022

Abstract

Material Business Division possesses advanced PLGA (Poly-Lactic-co-Glycolic Acid) nanoparticle technology having DDS (Drug Delivery System) characteristics. The PLGA nanoparticles proposed and provided by us have already been applied to not only drug formulation but also cosmetics, quasi-drugs, medical devices such as stent and balloon catheters. Since 2004, we have launched to sell both a functional skincare cosmetic brand "NanoCrysphere^®” and a haircare brand "NanoImpact^®” with the PLGA nanoparticles. Currently, we are also promoting ODM productions and sales for various types of unique cosmetics such as powdery serum and eyelash serum, etc., utilizing our PLGA nanoparticle technology.

Content from these authors

This article is licensed under a Creative Commons [Attribution 2.1 Japan] license.
https://creativecommons.org/licenses/by/2.1/jp/

Favorites & Alerts

Corresponding author

Register with J-STAGE for free!